Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Germany
/
Healthcare
/
Stratec
SBS
Stratec
Weak Product Launches Will Drag Performance Despite Emerging Opportunity
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 5 Analysts
Published
14 Jul 25
Updated
21 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€32.50
18.0% undervalued
intrinsic discount
21 Aug
€26.65
Loading
1Y
-39.4%
7D
4.7%
Author's Valuation
€32.5
18.0% undervalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€32.5
18.0% undervalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
304m
2014
2017
2020
2023
2025
2026
2028
Revenue €303.8m
Earnings €26.1m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
4.89%
Medical Equipment revenue growth rate
0.44%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.11%
Calculation
€26.06m
Earnings '28
x
17.88x
PE Ratio '28
=
€465.93m
Market Cap '28
€465.93m
Market Cap '28
/
12.16m
No. shares '28
=
€38.33
Share Price '28
€38.33
Share Price '28
Discounted to 2025 @ 6.11% p.a.
=
€32.08
Fair Value '25
